Perspectives of zebrafish models of epilepsy: What, how and where next?

Brain Research Bulletin

Volumn 87, Issue 2-3, 2012, Pages 135-143

  Stewart, Adam Michael ^a   Desmond, Daniel ^a   Kyzar, Evan ^a   Gaikwad, Siddharth ^a   Roth, Andrew ^a   Riehl, Russell ^a   Collins, Christopher ^a   Monnig, Louis ^a   Green, Jeremy ^a   Kalueff, Allan V ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiepileptic drugs; Biomarkers; Disease model; Epilepsy; Epileptogenesis; Seizure; Zebrafish

Indexed keywords

AMIDE; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BIOLOGICAL MARKER; CAFFEINE; GABAPENTIN; HYDANTOIN; KAINIC ACID; LAMOTRIGINE; PENICILLIN G; PENTETRAZOLE; PICROTOXIN; PILOCARPINE; PREGABALIN; PROGABIDE; PYRROLIDINE DERIVATIVE; STRYCHNINE; SUCCINIMIDE; SULFONAMIDE; TIAGABINE; TOPIRAMATE; TRIAZINE DERIVATIVE; VALPROIC ACID; VIGABATRIN;

ABSENCE; ANIMAL BEHAVIOR; ANTICONVULSANT THERAPY; BEHAVIORAL RESEARCH; BIOINFORMATICS; BRAIN FUNCTION; DISEASE MODEL; DRUG SCREENING; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTOGENESIS; GENETIC MODEL; HUMAN; INFORMATION TECHNOLOGY; MEDICAL RESEARCH; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TRANSLATIONAL RESEARCH; ZEBRA FISH;

ANIMALS; ANTICONVULSANTS; BRAIN; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; EPILEPSY; ZEBRAFISH;

EID: 84856618590     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.11.020     Document Type: Review

References (168)

1. Abidin I., et al. Penicillin induced epileptiform activity and EEG spectrum analysis of BDNF heterozygous mice: an in vivo electrophysiological study. Brain Res. Bull. 2011, 86(3-4):159-164.
2. Alfaro J.M., Ripoll-Gomez J., Burgos J.S. Kainate administered to adult zebrafish causes seizures similar to those in rodent models. Eur. J. Neurosci. 2011, 33(7):1252-1255.
3. Arai Y., et al. Effects of midazolam and phenobarbital on brain oxidative reactions induced by pentylenetetrazole in a convulsion model. Immunopharmacol. Immunotoxicol. 2011, in press.
4. Arida R.M., et al. Physical exercise in epilepsy: what kind of stressor is it?. Epilepsy Behav. 2009, 16(3):381-387.
5. Avoli M., et al. Cellular and molecular mechanisms of epilepsy in the human brain. Prog. Neurobiol. 2005, 77(3):166-200.
6. Baraban S.C. Modeling Epilepsy and Seizures in Developing Zebrafish Larvae. Models of Seizures and Epilepsy 2006, Academic Press, Burlington. A. Pitkänen, P.A. Schwartzkroin, S.L. Moshé (Eds.).
7. Baraban S.C. Emerging epilepsy models: insights from mice, flies, worms and fish. Curr. Opin. Neurol. 2007, 20(2):164-168.
8. Baraban S.C., et al. Pentylenetetrazole induced changes in zebrafish behavior: neural activity and c-fos expression. Neuroscience 2005, 131(3):759-768.
9. Baraban S.C., et al. A large-scale mutagenesis screen to identify seizure-resistant zebrafish. Epilepsia 2007, 48(6):1151-1157.
10. Barbazuk W.B., et al. The syntenic relationship of the zebrafish and human genomes. Genome Res. 2000, 10(9):1351-1358.
11. Beer J., et al. Expression of c-jun: junB, c-fos, fra-1 and fra-2 mRNA in the rat brain following seizure activity and axotomy. Brain Res. 1998, 794(2):255-266.
12. Beghi E., et al. Comment on epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005, 46(10):1698-1699. (author reply 1701-2).
13. Bencan Z., Sledge D., Levin E.D. Buspirone: chlordiazepoxide and diazepam effects in a zebrafish model of anxiety. Pharmacol. Biochem. Behav. 2009, 94(1):75-80.
14. Berghmans S., et al. Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants. Epilepsy Res. 2007, 75(1):18-28.
15. Blake J.A., et al. The Mouse Genome Database (MGD): premier model organism resource for mammalian genomics and genetics. Nucleic Acids Res. 2011, 39(Database issue):D842-D848.
16. Borges Fernandes L.C., Campos Camara C., Soto-Blanco B. Anticonvulsant activity of extracts of Plectranthus barbatus leaves in mice. Evid. Based Complement. Altern. Med. 2011, 2012:860153.
17. Bullitt E. Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. J. Comp. Neurol. 1990, 296(4):517-530.
18. Burgess H.A., Granato M. The neurogenetic frontier-lessons from misbehaving zebrafish. Brief. Funct. Genomic Proteomic 2008, 7(6):474-482.
19. Cachat J.M., et al. Three-dimensional neurophenotyping of adult zebrafish behavior. PLoS One 2011, 6(3):e17597.
20. Cachat J., et al. Measuring behavioral and endocrine responses to novelty stress in adult zebrafish. Nat. Protocols 2010, 5(11):1786-1799.
21. Cachat J.M., et al. Video-aided analysis of zebrafish locomotion and anxiety-related behavioral responses. Zebrafish Neurobehavioral Protocols 2010, Humana Press, New York. A.V. Kalueff, J. Cachat (Eds.).
22. Cachat J., et al. Modeling withdrawal syndrome in zebrafish. Behav. Brain Res. 2010, 208(2):371-376.
23. Cacheaux L.P., et al. Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J. Neurosci. 2009, 29(28):8927-8935.
24. Carballo-Quintas M., et al. A study of neurotoxic biomarkers: c-fos and GFAP after acute exposure to GSM radiation at 900MHz in the picrotoxin model of rat brains. Neurotoxicology 2011, 32(4):478-494.
25. Carmody S., Brennan L. Effects of pentylenetetrazole-induced seizures on metabolomic profiles of rat brain. Neurochem. Int. 2010, 56(2):340-344.
26. Cavalheiro E.A. The pilocarpine model of epilepsy. Ital. J. Neurol. Sci. 1995, 16(1-2):33-37.
27. Chakraborty C., et al. Zebrafish: a complete animal model for in vivo drug discovery and development. Curr. Drug Metab. 2009, 10(2):116-124.
28. Chan R.K., et al. A comparison of two immediate-early genes: c-fos and NGFI-B, as markers for functional activation in stress-related neuroendocrine circuitry. J. Neurosci. 1993, 13(12):5126-5138.
29. Chatt A.B., Ebersole J.S. Comparisons between strychnine and penicillin epileptogenesis suggest that propagating epileptiform abnormalities require the potentiation of thalamocortical circuitry in neocortical layer 4. Exp. Neurol. 1988, 100(2):365-380.
30. Chege S.W., et al. Expression and function of KCNQ channels in larval zebrafish. Dev. Neurobiol. 2011, in press.
31. Chen S., et al. Automated analysis of zebrafish images for phenotypic changes in drug discovery. J. Neurosci. Methods 2011, 200(2):229-236.
32. Cole A.J., Koh S., Zheng Y. Are seizures harmful: what can we learn from animal models?. Prog. Brain Res. 2002, 135:13-23.
33. de Bruijn E., Cuppen E., Feitsma H. Highly efficient ENU mutagenesis in zebrafish. Methods Mol. Biol. 2009, 546:3-12.
34. DePrato Primeaux S., et al. Experimentally induced attenuation of neuropeptide-Y gene expression in transgenic mice increases mortality rate following seizures. Neurosci. Lett. 2000, 287(1):61-64.
35. Desmond D., et al. Assessing epilepsy-related behavioral phenotypes in adult zebrafish. Zebrafish Protocols for Neurobehavioral Research 2012, Humana Press, New York. A.V. Kalueff, A.M. Stewart (Eds.).
36. Dillioglugil M.O., et al. Effect of pentylenetetrazole and sound stimulation induced single and repeated convulsive seizures on the MDA: GSH and NO levels, and SOD activities in rat liver and kidney tissues. Brain Res. Bull. 2010, 83(6):356-359.
37. Dlugos C.A., Rabin R.A. Ethanol effects on three strains of zebrafish: model system for genetic investigations. Pharmacol. Biochem. Behav. 2003, 74(2):471-480.
38. Dodge S., Weibel R., Forootan E. Revealing the physics of movement: comparing the similarity of movement characteristics of different types of moving objects. Comput. Environ. Urban Syst. 2009, 33(6):419-434.
39. Edwards H.E., Burnham W.M., MacLusky N.J. Partial and generalized seizures affect reproductive physiology differentially in the male rat. Epilepsia 1999, 40(11):1490-1498.
40. Eliceiri B.P., Gonzalez A.M., Baird A. Zebrafish model of the blood-brain barrier: morphological and permeability studies. Methods Mol. Biol. 2011, 686:371-378.
41. Evotec, Zebrafish Screening, ADMET and Zebrafish Screening, Hamburg, 2011.
42. Evotec Zebrafish Screening 2011, Evotec, Inc., Hamburg, Germany.
43. Fisher R.S., et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005, 46(4):470-472.
44. Fleisher W., et al. Comparative study of trauma-related phenomena in subjects with pseudoseizures and subjects with epilepsy. Am. J. Psychiatry 2002, 159(4):660-663.
45. Fontaine E., et al. Automated visual tracking for studying the ontogeny of zebrafish swimming. J. Exp. Biol. 2008, 211(Pt 8):1305-1316.
46. Frankel W.N. Genetics of complex neurological disease: challenges and opportunities for modeling epilepsy in mice and rats. Trends Genet. 2009, 25(8):361-367.
47. Galimberti C.A., et al. Seizure frequency and cortisol and dehydroepiandrosterone sulfate (DHEAS) levels in women with epilepsy receiving antiepileptic drug treatment. Epilepsia 2005, 46(4):517-523.
48. George A.L. Molecular basis of inherited epilepsy. Arch. Neurol. 2004, 61(4):473-478.
49. Gerlai R. A small fish with a big future: zebrafish in behavioral neuroscience. Rev. Neurosci. 2011, 22(1):3-4.
50. Gernert M., et al. Genetically engineered GABA-producing cells demonstrate anticonvulsant effects and long-term transgene expression when transplanted into the central piriform cortex of rats. Exp. Neurol. 2002, 176(1):183-192.
51. Getova D.P., Mihaylova A.S. A study of the effects of lamotrigine on mice using two convulsive tests. Folia Med. (Plovdiv) 2011, 53(2):57-62.
52. Giorgi O., et al. Anticonvulsant effect of felbamate in the pentylenetetrazole kindling model of epilepsy in the rat. Naunyn. Schmiedebergs Arch. Pharmacol. 1996, 354(2):173-178.
53. Gjini E., et al. Zebrafish Tie-2 shares a redundant role with Tie-1 in heart development and regulates vessel integrity. Dis. Model. Mech. 2011, 4(1):57-66.
54. Goldsmith P., et al. GBR12909 possesses anticonvulsant activity in zebrafish and rodent models of generalized epilepsy but cardiac ion channel effects limit its clinical utility. Pharmacology 2007, 79(4):250-258.
55. Gurnett C.A., Hedera P. New ideas in epilepsy genetics: novel epilepsy genes, copy number alterations, and gene regulation. Arch. Neurol. 2007, 64(3):324-328.
56. Hamani C., Mello L.E. Spontaneous recurrent seizures and neuropathology in the chronic phase of the pilocarpine and picrotoxin model epilepsy. Neurol. Res. 2002, 24(2):199-209.
57. Higashijima S., et al. Imaging neuronal activity during zebrafish behavior with a genetically encoded calcium indicator. J. Neurophysiol. 2003, 90(6):3986-3997.
58. Hirata H., et al. Zebrafish bandoneon mutants display behavioral defects due to a mutation in the glycine receptor beta-subunit. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(23):8345-8350.
59. Hoffman G.E., Smith M.S., Verbalis J.G. c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front. Neuroendocrinol. 1993, 14(3):173-213.
60. Hortopan G.A., Baraban S.C. Aberrant expression of genes necessary for neuronal development and notch signaling in an epileptic mind bomb zebrafish. Dev. Dyn. 2011, 240(8):1964-1976.
61. Hortopan G.A., Dinday M.T., Baraban S.C. Spontaneous seizures and altered gene expression in GABA signaling pathways in a mind bomb mutant zebrafish. J. Neurosci. 2010, 30(41):13718-13728.
62. Hortopan G.A., Dinday M.T., Baraban S.C. Zebrafish as a model for studying genetic aspects of epilepsy. Dis. Model. Mech. 2010, 3(3-4):144-148.
63. Huang L.T., et al. Pentylenetetrazol-induced recurrent seizures in rat pups: time course on spatial learning and long-term effects. Epilepsia 2002, 43(6):567-573.
64. Isenberg J.S., et al. Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid. Br. J. Pharmacol. 2007, 151(1):63-72.
65. Jeong J.Y., et al. Functional and developmental analysis of the blood-brain barrier in zebrafish. Brain Res. Bull. 2008, 75(5):619-628.
66. Kalueff A.V., Schmidt M.V. Novel experimental models and paradigms for neuropsychiatric disorders: editorial. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(6):1355-1356.
67. Kaminski R.M., Banerjee M., Rogawski M.A. Topiramate selectively protects against seizures induced by ATPA: a GluR5 kainate receptor agonist. Neuropharmacology 2004, 46(8):1097-1104.
68. Kari G., Rodeck U., Dicker A.P. Zebrafish: an emerging model system for human disease and drug discovery. Clin. Pharmacol. Ther. 2007, 82(1):70-80.
69. Ketzef M., et al. Compensatory network alterations upon onset of epilepsy in synapsin triple knock-out mice. Neuroscience 2011, 189:108-122.
70. Kjeldsen M.J., et al. Genetic and environmental factors in epilepsy: a population-based study of 11900 Danish twin pairs. Epilepsy Res. 2001, 44(2-3):167-178.
71. Kobow K., Blumcke I. The methylation hypothesis: do epigenetic chromatin modifications play a role in epileptogenesis?. Epilepsia 2011, 52(Suppl. 4):15-19.
72. Kobow K., et al. Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy. J. Neuropathol. Exp. Neurol. 2009, 68(4):356-364.
73. Kokaia M., et al. Seizure suppression in kindling epilepsy by intracerebral implants of GABA- but not by noradrenaline-releasing polymer matrices. Exp. Brain Res. 1994, 100(3):385-394.
74. Kovacs Z., et al. Intracerebroventricularly administered lipopolysaccharide enhances spike-wave discharges in freely moving WAG/Rij rats. Brain Res. Bull. 2011, 85(6):410-416.
75. Kumar G., et al. The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors. Psychoneuroendocrinology 2007, 32(7):834-842.
76. Kwan P., Brodie M.J. Early identification of refractory epilepsy. N. Engl. J. Med. 2000, 342(5):314-319.
77. E. Kyzar et al., The Zebrafish Neurophenome Database (ZND): a new open-access online resource for zebrafish neurophenotypic data, Zebrafish, in press.
78. Laming P.R., Rooney D.J., Ferguson J. Epileptogenesis is associated with heightened arousal responses in fish. Physiol. Behav. 1987, 40(5):617-624.
79. Lanaud P., et al. Temporal and spatial patterns of expression of c-fos: zif/268, c-jun and jun-B mRNAs in rat brain following seizures evoked focally from the deep prepiriform cortex. Exp. Neurol. 1993, 119(1):20-31.
80. LaPorte J.L., et al. Qui non proficit, deficit: experimental models for 'integrative' research of affective disorders. J. Affect. Disord. 2010, 121(1-2):1-9.
81. Lau B.Y., et al. Identification of a brain center whose activity discriminates a choice behavior in zebrafish. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(6):2581-2586.
82. Laube P. Progress in movement pattern analysis. Behaviour Monitoring and Interpretation - Ambient Assisted Living 2009, IOS Press. B. Gottfried, H. Aghajan (Eds.).
83. Lee Y., et al. Improvement of pentylenetetrazol-induced learning deficits by valproic acid in the adult zebrafish. Eur. J. Pharmacol. 2010, 643(2-3):225-231.
84. Li G., et al. Cytokines and epilepsy. Seizure 2011, 20(3):249-256.
85. Liu D.Z., et al. Brain and blood microRNA expression profiling of ischemic stroke: intracerebral hemorrhage, and kainate seizures. J. Cereb. Blood Flow Metab. 2010, 30(1):92-101.
86. Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res. 2002, 50(1-2):105-123.
87. Loscher W. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure 2011, 20(5):359-368.
88. Ludwig A., et al. Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2. EMBO J. 2003, 22(2):216-224.
89. Lukawski K., et al. Influence of ethacrynic acid on the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock seizure model. Pharmacol. Rep. 2010, 62(5):808-813.
90. Luszczki J.J., Andres M.M., Czuczwar S.J. Synergistic interaction of gabapentin and oxcarbazepine in the mouse maximal electroshock seizure model-an isobolographic analysis. Eur. J. Pharmacol. 2005, 515(1-3):54-61.
91. Luszczki J.J., et al. Furosemide potentiates the anticonvulsant action of valproate in the mouse maximal electroshock seizure model. Epilepsy Res. 2007, 76(1):66-72.
92. Luszczki J.J., et al. Effects of WIN 55,212-2 mesylate (a synthetic cannabinoid) on the protective action of clonazepam, ethosuximide, phenobarbital and valproate against pentylenetetrazole-induced clonic seizures in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(8):1870-1876.
93. Macdonald R.L., Barker J.L. Pentylenetetrazol and penicillin are selective antagonists of GABA-mediated post-synaptic inhibition in cultured mammalian neurones. Nature 1977, 267(5613):720-721.
94. Mani R., Pollard J., Dichter M.A. Human clinical trails in antiepileptogenesis. Neurosci. Lett. 2011, 497(3):251-256.
95. Marescaux C., Vergnes M., Depaulis A. Genetic absence epilepsy in rats from Strasbourg-a review. J. Neural Transm. Suppl. 1992, 35:37-69.
96. Marley R., Baines R.A. Increased persistent Na+ current contributes to seizure in the slamdance bang-sensitive Drosophila mutant. J. Neurophysiol. 2011, 106(1):18-29.
97. Maroso M., et al. Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 2011, 8(2):304-315.
98. Matagne A., et al. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714): a high-affinity ligand for the synaptic vesicle protein, SV2A. Br. J. Pharmacol. 2008, 154(8):1662-1671.
99. Matagne A., et al. Profile of the new pyrrolidone derivative seletracetam (ucb 44212) in animal models of epilepsy. Eur. J. Pharmacol. 2009, 614(1-3):30-37.
100. Mazarati A.M., et al. Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy. Neurobiol. Dis. 2009, 34(3):457-461.
101. Metscher B.D., Ahlberg P.E. Zebrafish in context: uses of a laboratory model in comparative studies. Dev. Biol. 1999, 210(1):1-14.
102. Najm I.M., et al. Temporal changes in proton MRS metabolites after kainic acid-induced seizures in rat brain. Epilepsia 1997, 38(1):87-94.
103. Normark M.B., Erdal J., Kjaer T.W. Video electroencephalography monitoring differentiates between epileptic and non-epileptic seizures. Dan. Med. Bull. 2011, 58(9):A4305.
104. Ottman R., et al. Relations of genetic and environmental factors in the etiology of epilepsy. Ann. Neurol. 1996, 39(4):442-449.
105. Pandey R., et al. Baccoside A suppresses epileptic-like seizure/convulsion in Caenorhabditis elegans. Seizure 2010, 19(7):439-442.
106. Papandrea D., et al. Dissociation of seizure traits in inbred strains of mice using the flurothyl kindling model of epileptogenesis. Exp. Neurol. 2009, 215(1):60-68.
107. Patil M.S., et al. Anticonvulsant activity of aqueous root extract of Ficus religiosa. J. Ethnopharmacol. 2011, 133(1):92-96.
108. Pesce M.E., et al. Progesterone and testosterone modulate the convulsant actions of pentylenetetrazol and strychnine in mice. Pharmacol. Toxicol. 2000, 87(3):116-119.
109. Phillips H.A., et al. Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24. Am. J. Hum. Genet. 1998, 63(4):1108-1116.
110. Pineda R., Beattie C.E., Hall C.W. Recording the adult zebrafish cerebral field potential during pentylenetetrazole seizures. J. Neurosci. Methods 2011, 200(1):20-28.
111. Pitkanen A., Lukasiuk K. Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav. 2009, 14(Suppl. 1):16-25.
112. Postlethwait J.H., et al. Zebrafish comparative genomics and the origins of vertebrate chromosomes. Genome Res. 2000, 10(12):1890-1902.
113. Qureshi I.A., Mehler M.F. Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis. Neurobiol. Dis. 2010, 39(1):53-60.
114. Rao R.S., Prakash A., Medhi B. Role of different cytokines and seizure susceptibility: a new dimension towards epilepsy research. Indian J. Exp. Biol. 2009, 47(8):625-634.
115. Rihel J., et al. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 2010, 327(5963):348-351.
116. Roberts A.J., Crabbe J.C., Keith L.D. Type I corticosteroid receptors modulate PTZ-induced convulsions of withdrawal seizure prone mice. Brain Res. 1993, 626(1-2):143-148.
117. Rohner N., et al. Enhancing the efficiency of N-ethyl-N-nitrosourea-induced mutagenesis in the zebrafish. Zebrafish 2011, 8(3):119-123.
118. Rosemberg D.B., et al. Differences in spatio-temporal behavior of zebrafish in the open tank paradigm after a short-period confinement into dark and bright environments. PLoS One 2011, 6(5):e19397.
119. Runke D., et al. Relation between startle reactivity and sucrose avidity in two rat strains bred for differential seizure susceptibility. Exp. Neurol. 2011, 229(2):259-263.
120. Russo E., et al. Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model. Epilepsia 2011, 52(7):1341-1350.
121. Salinsky M., et al. Psychogenic nonepileptic seizures in US veterans. Neurology 2011, 77(10):945-950.
122. Salomons A.R., et al. Behavioural habituation to novelty and brain area specific immediate early gene expression in female mice of two inbred strains. Behav. Brain Res. 2010, 215(1):95-101.
123. Salomons A.R., et al. Identifying emotional adaptation: behavioural habituation to novelty and immediate early gene expression in two inbred mouse strains. Genes Brain Behav. 2010, 9(1):1-10.
124. Scheffer I.E., Berkovic S.F. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 1997, 120(Pt 3):479-490.
125. Schridde U., van Luijtelaar G. Corticosterone increases spike-wave discharges in a dose- and time-dependent manner in WAG/Rij rats. Pharmacol. Biochem. Behav. 2004, 78(2):369-375.
126. Seale T.W., et al. Coincidence of seizure susceptibility to caffeine and to the benzodiazepine inverse agonist: DMCM, in SWR and CBA inbred mice. Pharmacol. Biochem. Behav. 1987, 26(2):381-387.
127. Siebel A.M., et al. In vitro effects of antiepileptic drugs on acetylcholinesterase and ectonucleotidase activities in zebrafish (Danio rerio) brain. Toxicol. In Vitro 2010, 24(4):1279-1284.
128. Siebel A.M., et al. PTZ-induced seizures inhibit adenosine deamination in adult zebrafish brain membranes. Brain Res. Bull. 2011, 86(5-6):385-389.
129. Signore I.A., et al. Zebrafish and medaka: model organisms for a comparative developmental approach of brain asymmetry. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2009, 364(1519):991-1003.
130. Sillanpaa M., Shinnar S. Long-term mortality in childhood-onset epilepsy. N. Engl. J. Med. 2010, 363(26):2522-2529.
131. Simmonds M.A. Classification of some GABA antagonists with regard to site of action and potency in slices of rat cuneate nucleus. Eur. J. Pharmacol. 1982, 80(4):347-358.
132. Siniscalchi A., et al. Serum prolactin levels in repetitive temporal epileptic seizures. Eur. Rev. Med. Pharmacol. Sci. 2008, 12(6):365-368.
133. Sloviter R.S. The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy. Ann. Neurol. 1994, 35(6):640-654.
134. Sood N., et al. Nicotine reversal of anticonvulsant action of topiramate in kainic acid-induced seizure model in mice. Nicotine Tob. Res. 2011, 13(11):1084-1089.
135. Spira M.E., Bennett M.V. Penicillin induced seizure activity in the hatchet fish. Brain Res. 1972, 43(1):235-241.
136. Sprague J., et al. The Zebrafish Information Network: the zebrafish model organism database provides expanded support for genotypes and phenotypes. Nucleic Acids Res. 2008, 36(Database issue):D768-D772.
137. Stables J.P., et al. Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland. Epilepsia 2002, 43(11):1410-1420.
138. Stankiewicz J., et al. Effects of repeated systemic penicillin injections on nonconvulsive and convulsive epileptic seizures in the rat. Acta Neurobiol. Exp. (Wars) 1995, 55(4):281-287.
139. Stankova L., Kubova H., Mares P. Anticonvulsant action of lamotrigine during ontogenesis in rats. Epilepsy Res. 1992, 13(1):17-22.
140. Steinlein O.K. Genetic mechanisms that underlie epilepsy. Nat. Rev. Neurosci. 2004, 5(5):400-408.
141. Stewart A., et al. The developing utility of zebrafish in modeling neurobehavioral disorders. Int. J. Comp. Psychol. 2010, 23(1):104-121.
142. Stewart A., et al. Pharmacological modulation of anxiety-like phenotypes in adult zebrafish behavioral models. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 35(6):1421-1431.
143. Stewart A., et al. Intraperitoneal injection as a method of psychotropic drug delivery in adult zebrafish. Zebrafish Neurobehavioral Protocols 2010, Humana Press, New York. A.V. Kalueff, J. Cachat (Eds.).
144. Stewart A., et al. Experimental models for anxiolytic drug discovery in the era of omes and omics. Expert Opin. Drug Discov. 2011, 6(1-15).
145. Szyndler J., et al. Mapping of c-Fos expression in the rat brain during the evolution of pentylenetetrazol-kindled seizures. Epilepsy Behav. 2009, 16(2):216-224.
146. Taher T.R., et al. Chronic low-dose corticosterone supplementation enhances acquired epileptogenesis in the rat amygdala kindling model of TLE. Neuropsychopharmacology 2005, 30(9):1610-1616.
147. Takechi K., Ishikawa T., Kamei C. Epileptogenic activity induced by teicoplanin and effects of some antiepileptics in mice. J. Pharmacol. Sci. 2008, 107(4):428-433.
148. Talmi M., et al. Synergistic action of corticosterone on kainic acid-induced electrophysiological alterations in the hippocampus. Brain Res. 1995, 704(1):97-102.
149. Tan N.C., Berkovic S.F. The Epilepsy Genetic Association Database (epiGAD): analysis of 165 genetic association studies, 1996-2008. Epilepsia 2010, 51(4):686-689.
150. Tao L., Lauderdale J.D., Sornborger A.T. Mapping functional connectivity between neuronal ensembles with larval zebrafish transgenic for a ratiometric calcium indicator. Front. Neural Circuits 2011, 5:2.
151. Teng Y., et al. Knockdown of zebrafish Lgi1a results in abnormal development: brain defects and a seizure-like behavioral phenotype. Hum. Mol. Genet. 2010, 19(22):4409-4420.
152. Thompson K.W., Suchomelova L.M. Transplants of cells engineered to produce GABA suppress spontaneous seizures. Epilepsia 2004, 45(1):4-12.
153. Tiedeken J.A., Ramsdell J.S. DDT exposure of zebrafish embryos enhances seizure susceptibility: relationship to fetal p,p'-DDE burden and domoic acid exposure of California sea lions. Environ. Health Perspect. 2009, 117(1):68-73.
154. Tiedeken J.A., Ramsdell J.S. Zebrafish seizure model identifies p,p-DDE as the dominant contaminant of fetal California sea lions that accounts for synergistic activity with domoic acid. Environ. Health Perspect. 2010, 118(4):545-551.
155. Tsankova N.M., Kumar A., Nestler E.J. Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J. Neurosci. 2004, 24(24):5603-5610.
156. Vohora D., et al. Effect of combined treatment of thioperamide with some antiepileptic drugs on methionine-sulfoximine induced convulsions in mice. Indian J. Exp. Biol. 2010, 48(8):858-860.
157. Volk H.A., Loscher W. Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures. Brain 2005, 128(Pt 6):1358-1368.
158. Wagnon J.L., et al. Etiology of a genetically complex seizure disorder in Celf4 mutant mice. Genes Brain Behav. 2011, 10(7):765-777.
159. Watanabe Y., et al. Effects of antiepileptics on behavioral and electroencephalographic seizure induced by pentetrazol in mice. J. Pharmacol. Sci. 2010, 112(3):282-289.
160. Williams L.R., et al. Behavioral and physiological effects of RDX on adult zebrafish. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2012, 155(1):33-38.
161. Wong K., et al. Modeling seizure-related behavioral and endocrine phenotypes in adult zebrafish. Brain Res. 2010, 1348:209-215.
162. Woods I.G., et al. A comparative map of the zebrafish genome. Genome Res. 2000, 10(12):1903-1914.
163. Wright D., et al. QTL analysis of behavioral and morphological differentiation between wild and laboratory zebrafish (Danio rerio). Behav. Genet. 2006, 36(2):271-284.
164. Wright D., Butlin R.K., Carlborg O. Epistatic regulation of behavioural and morphological traits in the zebrafish (Danio rerio). Behav. Genet. 2006, 36(6):914-922.
165. Zagrean L., et al. EEG study of kainate-induced epilepsy in non-anaesthetized freely moving rats. Rom. J. Physiol. 1993, 30(1-2):115-118.
166. Zapolsky I., et al. Utilizing the Zebrafish Neurophenome Project (ZNP). Database for analyses of complex neurophenotypes in zebrafish models. Zebrafish Protocols for Neurobehavioral Research 2012, Humana Press, New York. A.V. Kalueff, A.M. Stewart (Eds.).
167. Zhdanova I.V., et al. Melatonin promotes sleep-like state in zebrafish. Brain Res. 2001, 903(1-2):263-268.
168. Zhong X.L., et al. Deep brain stimulation for epilepsy in clinical practice and in animal models. Brain Res. Bull. 2011, 85(3-4):81-88.